<unk>  is contraindicated for co-administration with strong or moderate CYP3A inhibitors and inducers, as well as midazolam and certain cholesterol-lowering medications.
Lonafarnib
Tepotinib
Icotinib
Afatinib
Dabrafenib
Nilotinib
Lestaurtinib
Crizotinib